Bellicum reports second quarter 2020 financial results and provides operational update

Bellicum reports second quarter 2020 financial results and provides operational update.bellicum pharmaceuticals inc - qtrly loss per share $8.55.bellicum pharmaceuticals inc - cash and cash equivalents and restricted cash totaling $68.0 million as of june 30, 2020.

BLCM Ratings Summary

BLCM Quant Ranking